<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>News</title>
    <link>http://www.temasinergie.com/en/insights/news</link>
    <description>News</description>
    <language>en</language>
    <pubDate>Tue, 29 Sep 2026 11:28:10 GMT</pubDate>
    <dc:date>2026-09-29T11:28:10Z</dc:date>
    <dc:language>en</dc:language>
    <item>
      <title>RLT: A Complete GMP Line for the Safe and Efficient Production of Radiopharmaceuticals – The Case of IRST IRCCS in Meldola</title>
      <link>http://www.temasinergie.com/en/insights/news/rlt-linea-gmp-completa-produzione-sicura-efficiente-radiofarmaci-irst-irccs-meldola</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/rlt-linea-gmp-completa-produzione-sicura-efficiente-radiofarmaci-irst-irccs-meldola?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/meldola-immagine-evidenza.jpg" alt="meldola - featured image" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4 style="font-weight: normal;"&gt;In the ever-evolving field of Radioligand Therapy (RLT), the ability to produce radiopharmaceuticals safely, in compliance with regulations, and tailored to the diverse needs of each client is a critical factor for centers of excellence.&lt;/h4&gt; 
&lt;h4 style="font-weight: normal;"&gt;It is against this backdrop that the recent renovation of the radiopharmacy at the IRST “Dino Amadori” IRCCS in Meldola took place, where a Tema Sinergie RLT Production Line was installed, designed to ensure high standards of quality, safety, and operational performance.&lt;/h4&gt; 
&lt;h4&gt;&lt;strong&gt;This configuration represents a customized solution, tailored to the center’s specific production and operational needs, within a product line that can also include even more advanced levels of integration and automation.&lt;/strong&gt;&lt;/h4&gt;  
&lt;h4&gt;&lt;strong&gt;An integrated approach in accordance with GMP guidelines&lt;/strong&gt;&lt;/h4&gt; 
&lt;p&gt;The entire production workflow is developed in accordance with &lt;strong&gt;EU cGMP and GAMP5 guidelines,&lt;/strong&gt; with particular attention to operator safety, process sterility, and product integrity.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/rlt-linea-gmp-completa-produzione-sicura-efficiente-radiofarmaci-irst-irccs-meldola?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/meldola-immagine-evidenza.jpg" alt="meldola - featured image" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4 style="font-weight: normal;"&gt;In the ever-evolving field of Radioligand Therapy (RLT), the ability to produce radiopharmaceuticals safely, in compliance with regulations, and tailored to the diverse needs of each client is a critical factor for centers of excellence.&lt;/h4&gt; 
&lt;h4 style="font-weight: normal;"&gt;It is against this backdrop that the recent renovation of the radiopharmacy at the IRST “Dino Amadori” IRCCS in Meldola took place, where a Tema Sinergie RLT Production Line was installed, designed to ensure high standards of quality, safety, and operational performance.&lt;/h4&gt; 
&lt;h4&gt;&lt;strong&gt;This configuration represents a customized solution, tailored to the center’s specific production and operational needs, within a product line that can also include even more advanced levels of integration and automation.&lt;/strong&gt;&lt;/h4&gt;  
&lt;h4&gt;&lt;strong&gt;An integrated approach in accordance with GMP guidelines&lt;/strong&gt;&lt;/h4&gt; 
&lt;p&gt;The entire production workflow is developed in accordance with &lt;strong&gt;EU cGMP and GAMP5 guidelines,&lt;/strong&gt; with particular attention to operator safety, process sterility, and product integrity.&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Frlt-linea-gmp-completa-produzione-sicura-efficiente-radiofarmaci-irst-irccs-meldola&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiopharma Production</category>
      <pubDate>Tue, 29 Sep 2026 11:28:10 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/rlt-linea-gmp-completa-produzione-sicura-efficiente-radiofarmaci-irst-irccs-meldola</guid>
      <dc:date>2026-09-29T11:28:10Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>GammaPod has obtained the CE mark</title>
      <link>http://www.temasinergie.com/en/insights/news/gammapod-ha-ottenuto-il-marchio-ce</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/gammapod-ha-ottenuto-il-marchio-ce?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/GammaPod-CE-1.jpg" alt="GammaPod has obtained the CE mark" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;The certification of &lt;strong&gt;this&lt;/strong&gt; innovative &lt;strong&gt;system for stereotactic breast radiation therapy&lt;/strong&gt; paves the way for &lt;strong&gt;the first European installation&lt;/strong&gt; and opens the door to&lt;strong&gt; installations at other centers&lt;/strong&gt;.&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/gammapod-ha-ottenuto-il-marchio-ce?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/GammaPod-CE-1.jpg" alt="GammaPod has obtained the CE mark" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;The certification of &lt;strong&gt;this&lt;/strong&gt; innovative &lt;strong&gt;system for stereotactic breast radiation therapy&lt;/strong&gt; paves the way for &lt;strong&gt;the first European installation&lt;/strong&gt; and opens the door to&lt;strong&gt; installations at other centers&lt;/strong&gt;.&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Fgammapod-ha-ottenuto-il-marchio-ce&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiation Oncology</category>
      <pubDate>Thu, 17 Sep 2026 08:00:55 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/gammapod-ha-ottenuto-il-marchio-ce</guid>
      <dc:date>2026-09-17T08:00:55Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>GammaPodTM: unlocking a new era in breast cancer stereotactic radiotherapy</title>
      <link>http://www.temasinergie.com/en/insights/news/gammapodtm-unlocking-a-new-era-in-breast-cancer-stereotactic-radiotherapy</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/gammapodtm-unlocking-a-new-era-in-breast-cancer-stereotactic-radiotherapy?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/GAMMAPOD-webinar-in-evidenza.jpg" alt="Gammapod, Marco Trovo present the clinical trials in a educational webcast" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Three clinical trials: presentation and analysis of the results obtained throughout the months by Dr. Marco Trovò – Director of Radiation Oncology Department at University Hospital in Udine.&lt;/strong&gt;&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/gammapodtm-unlocking-a-new-era-in-breast-cancer-stereotactic-radiotherapy?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/GAMMAPOD-webinar-in-evidenza.jpg" alt="Gammapod, Marco Trovo present the clinical trials in a educational webcast" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Three clinical trials: presentation and analysis of the results obtained throughout the months by Dr. Marco Trovò – Director of Radiation Oncology Department at University Hospital in Udine.&lt;/strong&gt;&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Fgammapodtm-unlocking-a-new-era-in-breast-cancer-stereotactic-radiotherapy&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiation Oncology</category>
      <pubDate>Tue, 18 Aug 2026 09:06:28 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/gammapodtm-unlocking-a-new-era-in-breast-cancer-stereotactic-radiotherapy</guid>
      <dc:date>2026-08-18T09:06:28Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>First European patient to undergo stereotactic radiotherapy breast treatment with GammaPod™</title>
      <link>http://www.temasinergie.com/en/insights/news/first-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapod</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/first-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapod?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/Imported_Blog_Media/gammapod-anteprima-conferenza-stampa.jpg" alt="First European patient to undergo stereotactic radiotherapy breast treatment with GammaPod™" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Santa Maria della Misericordia hospital in Udine adopted GammaPod™, a groundbreaking technology specifically designed for breast cancer radiation treatments, for clinical use.&lt;/strong&gt;&lt;/h4&gt; 
&lt;p&gt;The press conference held on December 23rd 2021 by &lt;strong&gt;Azienda sanitaria universitaria Friuli Centrale&lt;/strong&gt; (ASU FC) made the clinical use of &lt;a href="https://www.temasinergie.com/product/gammapod/?hsLang=en"&gt;GammaPod™&lt;/a&gt; official. Actually, the first three patients in Europe underwent the radiation treatment with this brand new technology days prior to the official news release.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/first-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapod?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/Imported_Blog_Media/gammapod-anteprima-conferenza-stampa.jpg" alt="First European patient to undergo stereotactic radiotherapy breast treatment with GammaPod™" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Santa Maria della Misericordia hospital in Udine adopted GammaPod™, a groundbreaking technology specifically designed for breast cancer radiation treatments, for clinical use.&lt;/strong&gt;&lt;/h4&gt; 
&lt;p&gt;The press conference held on December 23rd 2021 by &lt;strong&gt;Azienda sanitaria universitaria Friuli Centrale&lt;/strong&gt; (ASU FC) made the clinical use of &lt;a href="https://www.temasinergie.com/product/gammapod/?hsLang=en"&gt;GammaPod™&lt;/a&gt; official. Actually, the first three patients in Europe underwent the radiation treatment with this brand new technology days prior to the official news release.&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Ffirst-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapod&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiation Oncology</category>
      <pubDate>Tue, 18 Aug 2026 08:50:20 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/first-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapod</guid>
      <dc:date>2026-08-18T08:50:20Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>AseptiFill, the new automatic vial filling and capping system in aseptic conditions</title>
      <link>http://www.temasinergie.com/en/insights/news/aseptifill-the-new-automatic-vial-filling-and-capping-system-in-aseptic-conditions</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/aseptifill-the-new-automatic-vial-filling-and-capping-system-in-aseptic-conditions?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/aseptifill-workflow-anteprima.jpg" alt="aseptifill-workflow-anteprima" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h6&gt;&lt;strong&gt;Specifically designed for Pharma &amp;amp; Biotech companies, &lt;/strong&gt;&lt;strong&gt;perfect for the production of small batches of injectable products.&lt;/strong&gt;&lt;/h6&gt; 
&lt;p&gt;&amp;nbsp;&lt;/p&gt; 
&lt;div class="hs-video-widget"&gt; 
 &lt;div class="hs-video-container" style="max-width: 1920px; margin: 0 auto;"&gt; 
  &lt;div class="hs-video-wrapper" style="position: relative; height: 0; padding-bottom: 56.67%"&gt;  
  &lt;/div&gt; 
 &lt;/div&gt; 
&lt;/div&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/aseptifill-the-new-automatic-vial-filling-and-capping-system-in-aseptic-conditions?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/aseptifill-workflow-anteprima.jpg" alt="aseptifill-workflow-anteprima" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h6&gt;&lt;strong&gt;Specifically designed for Pharma &amp;amp; Biotech companies, &lt;/strong&gt;&lt;strong&gt;perfect for the production of small batches of injectable products.&lt;/strong&gt;&lt;/h6&gt; 
&lt;p&gt;&amp;nbsp;&lt;/p&gt; 
&lt;div class="hs-video-widget"&gt; 
 &lt;div class="hs-video-container" style="max-width: 1920px; margin: 0 auto;"&gt; 
  &lt;div class="hs-video-wrapper" style="position: relative; height: 0; padding-bottom: 56.67%"&gt; 
   &lt;iframe sandbox="allow-forms allow-scripts allow-same-origin allow-popups" style="position: absolute !important; width: 100% !important; height: 100% !important; left: 0; top: 0; border: 0 none; pointer-events: initial"&gt;&lt;/iframe&gt; 
  &lt;/div&gt; 
 &lt;/div&gt; 
&lt;/div&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Faseptifill-the-new-automatic-vial-filling-and-capping-system-in-aseptic-conditions&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Pharma</category>
      <category>Biotech</category>
      <pubDate>Tue, 18 Aug 2026 08:26:34 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/aseptifill-the-new-automatic-vial-filling-and-capping-system-in-aseptic-conditions</guid>
      <dc:date>2026-08-18T08:26:34Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>New radiopharmaceutical production line for SWAN Isotopen signed by Tema Sinergie</title>
      <link>http://www.temasinergie.com/en/insights/news/new-radiopharmaceutical-production-line-swan-isotopen-tema-sinergie</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/new-radiopharmaceutical-production-line-swan-isotopen-tema-sinergie?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/Linea-Swan-Isotope-in-evidenza.jpg" alt="Radiopharmaceutical production line designed for Swan Isotoppen" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h6&gt;&lt;strong&gt;In the SWAN Isotopen’s laboratories, at Bern University Hospital, there is a new radiopharmaceutical production line coming into operation. This line is dedicated both to the development of new formulas requested by medical prescription and to the synthesis-and-dispensing process of radiopharmaceutical based on [18F] e [177Lu].&lt;/strong&gt;&lt;/h6&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/new-radiopharmaceutical-production-line-swan-isotopen-tema-sinergie?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/Linea-Swan-Isotope-in-evidenza.jpg" alt="Radiopharmaceutical production line designed for Swan Isotoppen" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h6&gt;&lt;strong&gt;In the SWAN Isotopen’s laboratories, at Bern University Hospital, there is a new radiopharmaceutical production line coming into operation. This line is dedicated both to the development of new formulas requested by medical prescription and to the synthesis-and-dispensing process of radiopharmaceutical based on [18F] e [177Lu].&lt;/strong&gt;&lt;/h6&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Fnew-radiopharmaceutical-production-line-swan-isotopen-tema-sinergie&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiopharma Production</category>
      <pubDate>Tue, 18 Aug 2026 07:55:18 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/new-radiopharmaceutical-production-line-swan-isotopen-tema-sinergie</guid>
      <dc:date>2026-08-18T07:55:18Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>Hundred treatments carried out and completed with GammaPodTM in Udine, Italy</title>
      <link>http://www.temasinergie.com/en/insights/news/100th-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapodtm-in-udine-italy</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/100th-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapodtm-in-udine-italy?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/Imported_Blog_Media/GAMMAPOD-webinar-1.jpg" alt="Hundred treatments carried out and completed with GammaPodTM in Udine, Italy" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) in Udine, Italy crosses the line of a hundred treatments carried out with GammaPod&lt;sup&gt;TM&lt;/sup&gt;, the brand new stereotactic radiotherapy system specifically designed for breast cancer, and approaches the publication of the first structured study gathering the data for this first phase of the trial.&lt;/strong&gt;&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/100th-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapodtm-in-udine-italy?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/Imported_Blog_Media/GAMMAPOD-webinar-1.jpg" alt="Hundred treatments carried out and completed with GammaPodTM in Udine, Italy" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) in Udine, Italy crosses the line of a hundred treatments carried out with GammaPod&lt;sup&gt;TM&lt;/sup&gt;, the brand new stereotactic radiotherapy system specifically designed for breast cancer, and approaches the publication of the first structured study gathering the data for this first phase of the trial.&lt;/strong&gt;&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2F100th-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapodtm-in-udine-italy&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiation Oncology</category>
      <pubDate>Tue, 18 Aug 2026 07:44:38 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/100th-european-patient-to-undergo-stereotactic-radiotherapy-breast-treatment-with-gammapodtm-in-udine-italy</guid>
      <dc:date>2026-08-18T07:44:38Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>Sterility Isolators: a complete range of solutions for microbiological quality control in the pharmaceutical field</title>
      <link>http://www.temasinergie.com/en/insights/news/sterility-isolators-complete-range-microbiological-quality-control-pharmaceutical-field</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/sterility-isolators-complete-range-microbiological-quality-control-pharmaceutical-field?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/Articolo-Gamma-isolatori-test-di-sterilita_main.jpg" alt="Sterility Isolators for QA and microbiology activities" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;ST-IS Series by Tema Sinergie offers a complete range of Sterility Isolators, fully compliant with the most stringent cGMP regulations and international laws, specifically designed for carrying out sterility tests and quality control activities in the pharmaceutical field.&lt;/strong&gt;&lt;/h4&gt; &amp;nbsp;
&lt;div class="hs-video-widget"&gt; 
 &lt;div class="hs-video-container" style="max-width: 1920px; margin: 0 auto;"&gt; 
  &lt;div class="hs-video-wrapper" style="position: relative; height: 0; padding-bottom: 56.25%"&gt;  
  &lt;/div&gt; 
 &lt;/div&gt; 
&lt;/div&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/sterility-isolators-complete-range-microbiological-quality-control-pharmaceutical-field?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/Articolo-Gamma-isolatori-test-di-sterilita_main.jpg" alt="Sterility Isolators for QA and microbiology activities" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;ST-IS Series by Tema Sinergie offers a complete range of Sterility Isolators, fully compliant with the most stringent cGMP regulations and international laws, specifically designed for carrying out sterility tests and quality control activities in the pharmaceutical field.&lt;/strong&gt;&lt;/h4&gt; &amp;nbsp;
&lt;div class="hs-video-widget"&gt; 
 &lt;div class="hs-video-container" style="max-width: 1920px; margin: 0 auto;"&gt; 
  &lt;div class="hs-video-wrapper" style="position: relative; height: 0; padding-bottom: 56.25%"&gt; 
   &lt;iframe sandbox="allow-forms allow-scripts allow-same-origin allow-popups" style="position: absolute !important; width: 100% !important; height: 100% !important; left: 0; top: 0; border: 0 none; pointer-events: initial"&gt;&lt;/iframe&gt; 
  &lt;/div&gt; 
 &lt;/div&gt; 
&lt;/div&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Fsterility-isolators-complete-range-microbiological-quality-control-pharmaceutical-field&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Pharma</category>
      <pubDate>Tue, 18 Aug 2026 07:28:18 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/sterility-isolators-complete-range-microbiological-quality-control-pharmaceutical-field</guid>
      <dc:date>2026-08-18T07:28:18Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>AGLTS 2: beyond glove leak testing</title>
      <link>http://www.temasinergie.com/en/insights/news/aglts-2-beyond-glove-leak-testing</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/aglts-2-beyond-glove-leak-testing?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/Imported_Blog_Media/AGLTS2-CST-IS-web1-1536x1024.png" alt="AGLTS 2: beyond glove leak testing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h6&gt;&lt;strong&gt;Tema Sinergie presents the new automatic glove test system developed in response to the requirements of the new Annex 1, EU Guidelines&lt;/strong&gt; &amp;nbsp;&amp;nbsp;&lt;/h6&gt; 
&lt;p&gt;The name is &lt;strong&gt;AGLTS 2&lt;/strong&gt;, and it’s the brand new automatic glove leak testing system designed for the pharmaceutical industry. The official launch was on April 25th at Interphex 2023, one of the most relevant trade shows for the pharmaceutical market in America.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/aglts-2-beyond-glove-leak-testing?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/Imported_Blog_Media/AGLTS2-CST-IS-web1-1536x1024.png" alt="AGLTS 2: beyond glove leak testing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h6&gt;&lt;strong&gt;Tema Sinergie presents the new automatic glove test system developed in response to the requirements of the new Annex 1, EU Guidelines&lt;/strong&gt; &amp;nbsp;&amp;nbsp;&lt;/h6&gt; 
&lt;p&gt;The name is &lt;strong&gt;AGLTS 2&lt;/strong&gt;, and it’s the brand new automatic glove leak testing system designed for the pharmaceutical industry. The official launch was on April 25th at Interphex 2023, one of the most relevant trade shows for the pharmaceutical market in America.&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Faglts-2-beyond-glove-leak-testing&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Nuclear Medicine</category>
      <category>Pharma</category>
      <category>Biotech</category>
      <category>Radiopharma Production</category>
      <pubDate>Tue, 18 Aug 2026 06:58:35 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/aglts-2-beyond-glove-leak-testing</guid>
      <dc:date>2026-08-18T06:58:35Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
    <item>
      <title>CRP Compact Plus, the answer to different GMP dispensing needs of radiopharmaceuticals</title>
      <link>http://www.temasinergie.com/en/insights/news/crp-compact-plus-radiopharmaceutical-vials-dispenser-push-fit-caps</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/crp-compact-plus-radiopharmaceutical-vials-dispenser-push-fit-caps?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/CRP-Compact_plus_Radiopharma_dispenser.jpg" alt="Automatic radiopharma dispenser system for vial with push-fit caps" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Tema Sinergie introduces CRP Compact Plus, the new version of the well-known and consolidated radiopharmaceutical dispenser specific for vials with Push-Fit caps.&lt;/strong&gt;&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="http://www.temasinergie.com/en/insights/news/crp-compact-plus-radiopharmaceutical-vials-dispenser-push-fit-caps?hsLang=en" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.temasinergie.com/hubfs/wordpress-import/tema-sinergie-blog/CRP-Compact_plus_Radiopharma_dispenser.jpg" alt="Automatic radiopharma dispenser system for vial with push-fit caps" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h4&gt;&lt;strong&gt;Tema Sinergie introduces CRP Compact Plus, the new version of the well-known and consolidated radiopharmaceutical dispenser specific for vials with Push-Fit caps.&lt;/strong&gt;&lt;/h4&gt;  
&lt;p&gt;&amp;nbsp;&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=146884147&amp;amp;k=14&amp;amp;r=http%3A%2F%2Fwww.temasinergie.com%2Fen%2Finsights%2Fnews%2Fcrp-compact-plus-radiopharmaceutical-vials-dispenser-push-fit-caps&amp;amp;bu=http%253A%252F%252Fwww.temasinergie.com%252Fen%252Finsights%252Fnews&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Radiopharma Production</category>
      <pubDate>Mon, 17 Aug 2026 14:56:41 GMT</pubDate>
      <guid>http://www.temasinergie.com/en/insights/news/crp-compact-plus-radiopharmaceutical-vials-dispenser-push-fit-caps</guid>
      <dc:date>2026-08-17T14:56:41Z</dc:date>
      <dc:creator>Tema Sinergie</dc:creator>
    </item>
  </channel>
</rss>
